Overall, trading for the year was in line with the Board's expectations. There was further progress in the like-for-like operating margin although revenue growth of approximately 13% was held back by the timing of contracts within Secondary Care. The Group delivered growth both organically and through the recently acquired businesses. The Group also maintained its customarily strong revenue visibility, order book and pipeline.
Read the full trading update.
Listen to Chris Spencer’s webcast: